Khosla Ventures invests in companies that are bold, early, and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech, digital health, medtech and diagnostics, therapeutics, and frontier technology.

Khosla Ventures

Y Combinator is a startup accelerator that invests in a large number of startups twice a year. It created a new model for funding startups. Twice a year, the company invests a small amount of money ($150k) in a large number of startups. The startup accelerator works intensively with the companies for three months, to get them into the best possible shape and refine their pitch to investors. Each cycle culminates in Demo Day when the startups present their companies to a carefully selected, invite-only audience.

Y Combinator

They are passionate about seeing their portfolio companies become successful.

Bantam Group

Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors. They support novel and evidence-based innovations that could produce an outsized return for the benefit of humankind. The firm specializes in the fields of business development, venture capital, and financial services.

Metaplanet

Longevitytech.fund do pre-seed and seed-stage investments in the best of worldwide early-stage startups and spinoffs based on our close cooperation with top scientists in the field of aging research and rejuvenation, biotechnology, bioinformatics, agetech, and related AI. We Provide an active approach with entrepreneurial help, network and commercialization support.  We also provide longevity program for our LPs.

Longevitytech.fund

Vituity is dedicated to bringing joy to the practice of medicine. As a nationwide, multispecialty partnership of top physicians

Vituity

Massachusetts has made a substantial commitment to develop the Manufacturing USA infrastructure within the state’s academic, research and manufacturing industry. Through the creation of sector-specific Manufacturing USA Centers, M2I2 will advance innovations and job growth within the state through cross-collaboration among companies, universities, national labs, government, incubators, accelerators and other academic and training institutions.

Mass. Manufacturing Innovation Initiative

R-Squared: “A model intended to predict future outcomes”. And the two Roy's behind it.  We're an 'angel fund'. We're operators. Entrepreneurs, founders and CEOs that started, ran, scaled and sold start-up companies. Then as corporate executives post the acquisition. Invested as angels in over two dozen start-up companies. Passionate about supporting the companies and the founders we're backing.  R-Squared Ventures was founded as an extension to our personal investments. Now backed by over three dozen top entrepreneurs, founders, CEOs and investors that are our LPs - in Silicon Valley and Israel - that want to be part of our investments and extend their experience, network and support to our companies.  We're excited about backing strong founders - with the drive, passion and ability to execute on a real problem, in a sizable market, with a big vision, and a defensible solution and path to succeed.  Mainly focused on Fintech, Enterprise/SMB SaaS, Marketplaces and Digital Commerce. Though we also invested in other categories, such as B2C companies, Gaming, AgTech, and others.

R-Squared Ventures

Intel Capital invests in innovative startups targeting cloud and AI infrastructure, edge, 5G, autonomy, cybersecurity, client & gaming, enterprise applications, silicon design and manufacturing, and a wide range of other disruptive technologies. Since 1991, Intel Capital has invested US$12.9 billion in more than 1,582 companies worldwide. Intel Capital has adopted the Diversity Term Sheet Rider.

Intel Capital

Alumni Ventures Group provides high-quality, diversified venture portfolios to individual investors who previously haven't had access to VC. It helps accredited alums from top entrepreneurial schools invest together in the ventures of fellow alums. The firm backs companies with an alumni connection and an institutional lead investor with expertise in the space. AVG also offers focused funds that allow any accredited investor access to a venture portfolio, diversified by type, sector, stage, and geography. Beth Obermiller, Michael Madden, and Mike Collins co-founded the firm in Manchester, New Hampshire in 2013.

Alumni Ventures

LongeVC was created to support early-stage biotech and longevity-focused founders on their way to gain industrial momentum, raise capital, and grow to become the shapers of tomorrow's biotech industry.

LongeVC

Kortex Ventures is a global venture capital fund that invests mainly in health tech and healthcare technology early-stage companies. It partners with outstanding entrepreneurs and innovative companies to change the future of healthcare through technology.

Kortex Ventures

Castor Ventures is an investment firm. Castor Ventures invests in a broad range of venture-backed companies to build diversified venture portfolios invested alongside established venture firms.

Castor Ventures

We believe everything relates back to how we operate or the effects human existence has had on the planet. We make Seed and Series A investments into companies that use science and tech to catalyze sea changes in health and climate. We also actively seek teams building frontier tech within other verticals.

Shorewind Capital

Learn more here: umamicap.com Apply to join here: https://angel.co/s/umami-capital/pzvRR

Umami Capital

Overlap Holdings is a venture capital firm that seeks to accelerate the pace of positive technological change in society.

Overlap Holdings

Duke Capital Partners' investment process educates the next generation of investment professionals and startup founders through their associate program. If you want any information please contact them through email or phone call.

Duke Capital Partners

SiPhox Health

SiPhox Health builds next-generation diagnostics infrastructure both for the home and the central lab. The SiPhox Health at-home test kit assesses 17 blood biomarkers related to inflammation, hormonal health, metabolic fitness, and cardiovascular health.

SiPhox Health, founded in 2020 by MIT scientists Diedrik Vermeulen and Michael Dubrovsky, is pioneering advanced blood testing technology using silicon photonic chip technology. The company's goal is to make lab-grade health testing accessible in every home. SiPhox Health's flagship product, the SiPhox Home platform, is designed to offer a broad menu of protein and hormone tests from a finger-prick blood sample, delivering results in under five minutes. The device aims to be significantly lighter (1 lb. vs.. 500 lbs.) and cheaper (USD 300 vs.. USD 500k) than traditional lab equipment. The company is working toward FDA clearance for this platform.

Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing

SiPhox Health Introduces World's First Lab-Quality Home Blood Testing Platform at CES

What We Measure

SiPhox Health: Convenient, Lab-Quality Home Testing

SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics

At-Home Blood Testing Just Got a Whole Lot Better

At-Home Health Testing

SiPhox Health Introduces Lab-Quality Home Blood Test Platform at CES

Intel Capital, Khosla lead $27M investment into SiPhox Health’s at-home blood-testing tech

SiPhox Health Reviews

Redefining hospital care with the comfort of home

Hospital-at-Home

RxSugar® and SiPhox Health Partner to Combat the Epidemic of Diet-related Disease

SiPhox Health, founded in 2020 by MIT scientists Diedrik Vermeulen and Michael Dubrovsky, is pioneering advanced blood testing technology using silicon photonic chip technology. The company's goal is to make lab-grade health testing accessible in every home. SiPhox Health's flagship product, the SiPhox Home platform, is designed to offer a broad menu of protein and hormone tests from a finger-prick blood sample, delivering results in under five minutes. The device aims to be significantly lighter (1 lb. vs.. 500 lbs.) and cheaper (USD 300 vs.. USD 500k) than traditional lab equipment. The company is working toward FDA clearance for this platform.
While developing its at-home device, SiPhox Health currently offers a mail-in blood collection kit that measures 17 biomarkers for inflammation, metabolic, hormonal, and cardiovascular health. The company's testing approach focuses on miniaturizing all components onto silicon chips, inheriting the functionality, multiplexing capability, and sensitivity of traditional lab instruments. SiPhox Health's subscription-based model offers test kits for USD 95 with a monthly membership of USD 16, which includes access to continuous glucose monitors and personalized biohacking tools.
The company's technology leverages silicon photonics, a semiconductor technology that has transformed internet connectivity, to enable testing that is claimed to be 100 times smaller, faster, and cheaper than existing solutions. SiPhox Health's long-term vision includes developing wearable devices for continuous real-time monitoring of biomarkers, potentially revolutionizing how individuals track and manage their health.

<div>
 
 AdaptHealth is a network of full-service medical equipment companies that provides tailored products and services to enable patients to live their best lives at home rather than in hospitals. The company offers a wide range of medical equipment and supplies, including CPAP machines, oxygen units, walkers, and compression socks. AdaptHealth's business model focuses on delivering healthcare solutions that fit into patients' everyday lives, with offerings that span from doctor's prescriptions to doorstep delivery.
 
 
 
 
 The company emphasizes customer service and satisfaction as its primary concern, providing online support to answer questions and a team of customer service representatives to help patients choose the right supplies. AdaptHealth also offers fast and convenient shipping directly to patients' homes. In November 2020, AdaptHealth acquired New England Home Medical Equipment (NEHME), a leading supplier of continuous glucose monitoring (CGM) and diabetes management supplies in the New England and Northeastern US. NEHME generated net revenues of approximately USD 31 million for the twelve months ended September 30, 2020, contributing to AdaptHealth's expansion in the diabetes care sector.
 
 
 
 
 Key customers and partnerships
 
 
 
 
 
 AdaptHealth serves a diverse range of patients with various medical needs, including those requiring CPAP machines for sleep apnea, oxygen therapy, mobility aids, and diabetes management supplies. The company's customer base includes individuals with chronic medical conditions who require ongoing support and medical equipment. Through its acquisition of NEHME, AdaptHealth expanded its reach to diabetes patients throughout New England and the Northeastern US.
 
</div>

AdaptHealth

DispatchHealth is a Denver-based healthcare company that provides comprehensive in-home medical care services across the US. Founded in 2013, the company aims to transform healthcare delivery by offering high-acuity care in the comfort of patients' homes. DispatchHealth's services include same-day urgent medical care, hospital alternative care, and recovery care. The company employs teams of emergency medicine and internal medicine trained professionals, including nurse practitioners, physician assistants, and emergency medical technicians, who are equipped with advanced medical tools and technologies to treat a wide range of conditions typically handled in emergency rooms or urgent care centers.
DispatchHealth's care model utilizes a proprietary technology platform that manages various aspects of the in-home care experience, including logistics, onboarding, risk stratification, care coordination, and analytics. This platform enables real-time data insights to improve patient outcomes. The company's services are designed to reduce unnecessary emergency room visits, hospital stays, and readmissions, resulting in significant cost savings for the healthcare system. As of December 2023, DispatchHealth reported treating more than one million patients across more than 30 states, leading to a 58% reduction in emergency room visits, an 8.5% 30-day hospital readmission rate, and nearly USD 1.5 billion in medical cost savings.
Key customers and partnerships
DispatchHealth has established partnerships with various healthcare stakeholders, including health plans, provider groups, health systems, employers, senior living facilities, and home health organizations. In May 2023, the company announced a collaboration with Included Health to enhance virtual-to-in-home care delivery, enabling Included Health's virtual primary care clinicians to coordinate with DispatchHealth's in-home clinical services.
DispatchHealth also formed a partnership with Instacart in January 2024 to address food insecurity among patients. This collaboration allows DispatchHealth's medical professionals to provide digital food stipends, offer medically tailored shopping lists, and send food directly to patients' homes.
In the Spokane area, DispatchHealth partnered with MultiCare Health System in August 2019 to improve healthcare access for at-risk patient populations. The company works with almost all major insurance companies, including Medicare and parts of Medicaid, to reduce the cost of care significantly.

DispatchHealth

Honor Technology, Inc. is a home care company that operates a technology-enabled platform to provide care services for older adults. Founded in 2014, Honor combines local care, 24/7 support, and advanced technology through its proprietary Honor Care Platform. This platform utilizes dynamic scheduling software and machine learning to optimize caregiver-client matching based on skills, commute times, and other factors. It also assists with caregiver recruiting, training, scheduling, and performance analysis.
In August 2021, Honor acquired Home Instead, one of the largest home care providers globally. This acquisition expanded Honor's reach significantly, with the combined company representing over USD 2.1 billion in revenue as of October 2021. Honor's technology aims to improve efficiency and care quality across its network of caregivers and partner agencies.
The company offers various services through different arms of its business. Honor Expert, launched in April 2022, is an online and mobile service that connects older adults and their families with resources, tools, and services related to aging and health issues. Honor also operates the Honor Care Network, which partners with independent home care agencies to provide back-office support, technology, and operational expertise in exchange for a share of revenue.
Key customers and partnerships
Honor has established partnerships with several national companies to enhance its service offerings. As of April 2022, Honor Expert had 14 national partners, including Amazon Business, Best Buy, SelectRX, and Freshly. These partnerships aim to provide users with access to a range of products and services addressing various aging-related needs.
The company's acquisition of Home Instead significantly expanded its customer base. Home Instead operates in 12 countries and has over 600 franchised locations in the US alone. This expansion has allowed Honor to serve clients across a wider geographic area and potentially develop contracts with national insurance carriers or major health systems.
Honor also partners with independent home care agencies through its Honor Care Network. These partnerships allow smaller agencies to benefit from Honor's technology and operational capabilities while maintaining their local presence and client relationships.

Honor

Alto Pharmacy is a digital pharmacy platform founded in 2015 by former Facebook engineers Jamie Karraker and Mattieu Gamache-Asselin. The company aims to simplify the prescription process and improve medication adherence through its technology-enabled solution. Alto's platform streamlines coordination between patients, doctors, and insurance companies, offering free same-day prescription delivery, lower costs on medications, and access to pharmacist support.
Alto's services include a mobile app for patients to manage their prescriptions, set reminders, and chat with pharmacists. The company also offers Alto Connect, a mobile app for doctors' offices to streamline prescription management and communication. Alto specializes in delivering medications for various conditions, including HIV, hepatitis C, asthma, rheumatology, and cardiology, among others.
As of 2022, Alto Pharmacy operates in 13 markets across the US, including major cities like San Francisco, Los Angeles, New York, and Houston. The company has experienced rapid growth, with its annual revenue reaching USD 700 million in 2022 and projections to cross the USD 1 billion mark by the end of that year. Alto has delivered over 4 million prescriptions to hundreds of thousands of patients and claims to have provided more than USD 120 million in savings to date.

Alto Pharmacy

LetsGetChecked is a healthcare solutions company that provides at-home diagnostic testing kits and virtual care services. Founded in 2015 by Peter Foley, the company offers over 30 different health tests covering areas such as sexual health, women's health, men's health, general wellness, and Covid-19. LetsGetChecked's testing process involves customers ordering a kit online, collecting their sample at home, and mailing it back to CLIA-certified and CAP-accredited laboratories for analysis. Results are typically available within 2-5 days through a secure online portal. The company utilizes biomarkers to analyze health conditions and employs highly accurate testing methods like NAAT PCR and electrochemiluminescence arrays for certain tests. In November 2023, LetsGetChecked achieved a significant milestone when the FDA granted marketing authorization for its Simple 2 Test, the first at-home test for chlamydia and gonorrhea. The company has expanded its services to include telehealth consultations and prescription delivery, aiming to provide a comprehensive healthcare solution. LetsGetChecked operates its own manufacturing facilities and laboratories, allowing for quality control throughout the testing process. As of 2024, the company has delivered over 7 million tests and serves more than 30 markets globally.
Key customers and partnerships
LetsGetChecked has partnered with over 300 corporate customers to provide testing services and biometric screening solutions. The company has also collaborated with major retailers and healthcare providers. In 2023, LetsGetChecked announced a partnership with PatientsLikeMe (PLM), a community health network, to offer PLM members access to testing at discounted prices. Additionally, the company has worked with UnitedHealthcare, Optum, HSA Store, FSA Store, and CVS Pharmacy. LetsGetChecked's services are available nationwide in the US, the UK, and most EU countries, with co-headquarters in Dublin and New York.

LetsGetChecked

Digital platforms that connect patients with in-person medical care providers in the comfort of their homes and support care delivery

Platforms enabling healthcare providers to order in-home therapies, durable medical equipment, and provide virtual acute care services

Companies offering a full-stack of in-home medical services including health evaluations, virtual and in-person visits for a variety of needs, and care coordination by leveraging data analytics

Platforms providing accessible lab testing solutions for a range of conditions, allowing patients to conveniently perform tests in their own homes

Digital pharmacies that deliver prescription medications directly to patients' homes and platforms that help track and manage medication adherence

Solutions enabling hospitals to establish hospital-at-home programs and providing workflow management tools for home care providers

SiPhox Health

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless